Integral Diagnostics Limited (ASX:IDX)
2.810
-0.040 (-1.40%)
Sep 26, 2025, 4:10 PM AEST
Integral Diagnostics Market Cap
Integral Diagnostics has a market cap or net worth of 1.05 billion as of September 26, 2025. Its market cap has increased by 74.76% in one year.
Market Cap
1.05B
Enterprise Value
1.58B
Revenue
627.22M
Ranking
n/a
PE Ratio
186.55
Stock Price
2.81
Market Cap Chart
Since October 21, 2015, Integral Diagnostics's market cap has increased from 263.77M to 1.05B, an increase of 296.74%. That is a compound annual growth rate of 14.87%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 26, 2025 | 1.05B | -3.27% |
Dec 31, 2024 | 1.08B | 143.25% |
Dec 29, 2023 | 444.76M | -34.84% |
Dec 30, 2022 | 682.57M | -31.87% |
Dec 31, 2021 | 1.00B | 16.26% |
Dec 31, 2020 | 861.69M | 15.95% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Oct 21, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 93.96B |
Pro Medicus | 31.54B |
Cochlear | 18.31B |
Sonic Healthcare | 10.45B |
Ramsay Health Care | 7.31B |
Telix Pharmaceuticals | 5.03B |
Ansell | 4.57B |
Mesoblast | 3.07B |